Tomosugi M - Search Results

1

MEK Inhibitor Suppresses Expression of the miR-17-92 Cluster with G1-Phase Arrest in HT-29 Human Colon Cancer Cells and MIA PaCa-2 Pancreatic Cancer Cells.

Tanaka R, Tomosugi M, Sakai T, Sowa Y. Tanaka R, et al. Among authors: tomosugi m. Anticancer Res. 2016 Sep;36(9):4537-43. doi: 10.21873/anticanres.11001. Anticancer Res. 2016. PMID: 27630293

2

Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells.

Tanaka R, Tomosugi M, Horinaka M, Sowa Y, Sakai T. Tanaka R, et al. Among authors: tomosugi m. PLoS One. 2015 May 8;10(5):e0125779. doi: 10.1371/journal.pone.0125779. eCollection 2015. PLoS One. 2015. PMID: 25955843 Free PMC article.

3

Myeloid zinc finger 1 mediates sulindac sulfide-induced upregulation of death receptor 5 of human colon cancer cells.

Horinaka M, Yoshida T, Tomosugi M, Yasuda S, Sowa Y, Sakai T. Horinaka M, et al. Among authors: tomosugi m. Sci Rep. 2014 Aug 8;4:6000. doi: 10.1038/srep06000. Sci Rep. 2014. PMID: 25102912 Free PMC article.

4

Ibuprofen enhances TRAIL-induced apoptosis through DR5 upregulation.

Todo M, Horinaka M, Tomosugi M, Tanaka R, Ikawa H, Sowa Y, Ishikawa H, Fujiwara H, Otsuji E, Sakai T. Todo M, et al. Among authors: tomosugi m. Oncol Rep. 2013 Nov;30(5):2379-84. doi: 10.3892/or.2013.2713. Epub 2013 Aug 30. Oncol Rep. 2013. PMID: 24002210

5

Retinoblastoma gene-independent G1 phase arrest by flavone, phosphatidylinositol 3-kinase inhibitor, and histone deacetylase inhibitor.

Tomosugi M, Sowa Y, Yasuda S, Tanaka R, te Riele H, Ikawa H, Koyama M, Sakai T. Tomosugi M, et al. Cancer Sci. 2012 Dec;103(12):2139-43. doi: 10.1111/cas.12012. Epub 2012 Oct 26. Cancer Sci. 2012. PMID: 22957647 Free PMC article.

6

Histone deacetylase inhibitors and 15-deoxy-Delta12,14-prostaglandin J2 synergistically induce apoptosis.

Koyama M, Izutani Y, Goda AE, Matsui TA, Horinaka M, Tomosugi M, Fujiwara J, Nakamura Y, Wakada M, Yogosawa S, Sowa Y, Sakai T. Koyama M, et al. Among authors: tomosugi m. Clin Cancer Res. 2010 Apr 15;16(8):2320-32. doi: 10.1158/1078-0432.CCR-09-2301. Epub 2010 Apr 6. Clin Cancer Res. 2010. PMID: 20371690

7

Aclarubicin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis through death receptor 5 upregulation.

Horinaka M, Yoshida T, Nakata S, Shiraishi T, Tomosugi M, Yoshikawa S, Wakada M, Sakai T. Horinaka M, et al. Among authors: tomosugi m. Cancer Sci. 2012 Feb;103(2):282-7. doi: 10.1111/j.1349-7006.2011.02150.x. Epub 2011 Dec 13. Cancer Sci. 2012. PMID: 22077238 Free article.

8

Mevalonate pathway blockage enhances the efficacy of mTOR inhibitors with the activation of retinoblastoma protein in renal cell carcinoma.

Hagiwara N, Watanabe M, Iizuka-Ohashi M, Yokota I, Toriyama S, Sukeno M, Tomosugi M, Sowa Y, Hongo F, Mikami K, Soh J, Fujito A, Miyashita H, Morioka Y, Miki T, Ukimura O, Sakai T. Hagiwara N, et al. Among authors: tomosugi m. Cancer Lett. 2018 Sep 1;431:182-189. doi: 10.1016/j.canlet.2018.05.025. Epub 2018 May 17. Cancer Lett. 2018. PMID: 29778569

9

Biosynthesis of castor oil: effect of polyamines on the acylation of lysophosphatidic acid at the sn-2 position with ricinoleic acid.

Tomosugi M, Ohshiro A, Hara S, Ichihara K. Tomosugi M, et al. Biosci Biotechnol Biochem. 2007 Aug;71(8):2052-6. doi: 10.1271/bbb.70044. Epub 2007 Aug 7. Biosci Biotechnol Biochem. 2007. PMID: 17690446 Free article.

10

Synthesis of phosphatidylcholine: an improved method without using the cadmium chloride complex of sn-glycero-3-phosphocholine.

Ichihara K, Iwasaki H, Ueda K, Takizawa R, Naito H, Tomosugi M. Ichihara K, et al. Among authors: tomosugi m. Chem Phys Lipids. 2005 Oct;137(1-2):94-9. doi: 10.1016/j.chemphyslip.2005.06.001. Chem Phys Lipids. 2005. PMID: 16054615

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results